{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:23:15Z","timestamp":1783164195239,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","award":["DGSSR-2025-01-01258"],"award-info":[{"award-number":["DGSSR-2025-01-01258"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11490-w","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:50:35Z","timestamp":1771944635000},"page":"6023-6037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, and antibacterial efficacy of new methylene disalicylic acid\/1,3,4-oxadiazole hybrids as dual inhibitors of DNA gyrase and topoisomerase IV"],"prefix":"10.1007","volume":"30","author":[{"given":"Fatma A. M.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad H.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelbaset Mohamed","family":"Elasbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awadh","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham A. M.","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha Y. M.","family":"Alakilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Yahya Abdullah","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar A.","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa A.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-6548","authenticated-orcid":false,"given":"Bahaa G. M.","family":"Youssif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwat M.","family":"Rabea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"12","key":"11490_CR1","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.1007\/s00210-024-03318-x","volume":"397","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Castagna T, Pantolini B, Campanardi MC, Roperti M, Grotto A et al (2024) The challenge of antimicrobial resistance (AMR): current status and future prospects. Naunyn-Schmiedebergs Arch Pharmacol 397(12):9603\u20139615","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"11490_CR2","doi-asserted-by":"crossref","unstructured":"Tendulkar M, Tendulkar R (2026) Analysis of antimicrobial resistance and climate change: a global threat. Antimicrobial Res Hum Anim Environ 233\u201346","DOI":"10.1016\/B978-0-443-33702-4.00011-6"},{"issue":"10459","key":"11490_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE et al (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. The Lancet 404(10459):1199\u20131226","journal-title":"The Lancet"},{"key":"11490_CR4","doi-asserted-by":"publisher","first-page":"108101","DOI":"10.1016\/j.bioorg.2024.108101","volume":"155","author":"HK Abd El-Mawgoud","year":"2025","unstructured":"Abd El-Mawgoud HK, AboulMagd AM, Shaker AM, Hemdan MM, Hassaballah AI, Farag PS (2025) Synthesis of tetra-substituted thiophene derivatives as potential hits combating antibiotic resistant bacteria ESKAPE. Bioorg Chem 155:108101","journal-title":"Bioorg Chem"},{"key":"11490_CR5","doi-asserted-by":"crossref","unstructured":"Mancuso G, Midiri A, Gerace E, Biondo C (2021) Bacterial antibiotic resistance: the most critical pathogens. Pathogens 2021, 10, 1310. s Note: MDPI stays neu-tral with regard to jurisdictional claims in","DOI":"10.3390\/pathogens10101310"},{"key":"11490_CR6","doi-asserted-by":"crossref","unstructured":"Senghore M, Thomsen J, Abdulrazzaq NM, Chen W, Kaambo E, Weber S, et al. (2026) Evolving landscape of respiratory infections and AMR in the UAE: a 12-year nationwide study of regional burden, epidemiologic trends and policy implications. Int J Infect Dis 108389","DOI":"10.1016\/j.ijid.2026.108389"},{"key":"11490_CR7","doi-asserted-by":"crossref","unstructured":"Sigudu TT, Oguttu JW, Qekwana DN (2024) Antimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012\u20132017. Microorganisms 12(9):1862","DOI":"10.3390\/microorganisms12091862"},{"key":"11490_CR8","doi-asserted-by":"crossref","unstructured":"Xu J, Liu J, Li X, Zhao L, Shen J, Xia X (2025) Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050. J Adv Res","DOI":"10.1016\/j.jare.2025.06.021"},{"issue":"5","key":"11490_CR9","doi-asserted-by":"publisher","first-page":"e0013140","DOI":"10.1371\/journal.pntd.0013140","volume":"19","author":"N Ackam","year":"2025","unstructured":"Ackam N, Akenten CW, Boadi AO, Agbanyo A, Abass KM, Amofa G et al (2025) Antimicrobial resistant bacteria isolated from Buruli ulcer lesions in Ghana. PLoS Negl Trop Dis 19(5):e0013140","journal-title":"PLoS Negl Trop Dis"},{"key":"11490_CR10","doi-asserted-by":"publisher","first-page":"134049","DOI":"10.1016\/j.molstruc.2022.134049","volume":"1271","author":"SA Abdel-Aziz","year":"2023","unstructured":"Abdel-Aziz SA, Cirnski K, Herrmann J, Abdel-Aal MA, Youssif BG, Salem OI (2023) Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: design, synthesis, and biological evaluation. J Mol Struct 1271:134049","journal-title":"J Mol Struct"},{"key":"11490_CR11","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.4c00880","author":"I Faheem","year":"2025","unstructured":"Faheem I, Nagaraja V (2025) Multifunctional Mycobacterial topoisomerases with distinctive features. ACS Infect Dis. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00880","journal-title":"ACS Infect Dis"},{"issue":"11","key":"11490_CR12","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1093\/nar\/gkab270","volume":"49","author":"J Hirsch","year":"2021","unstructured":"Hirsch J, Klostermeier D (2021) What makes a type IIA topoisomerase a gyrase or a Topo IV? Nucleic Acids Res 49(11):6027\u20136042","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11490_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-biochem-061809-100002","volume":"82","author":"SH Chen","year":"2013","unstructured":"Chen SH, Chan N-L, Hsieh T-s (2013) New mechanistic and functional insights into DNA topoisomerases. Annu Rev Biochem 82(1):139\u2013170","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"11490_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/13543776.2019.1575362","volume":"29","author":"M Durcik","year":"2019","unstructured":"Durcik M, Toma\u0161i\u010d T, Zidar N, Zega A, Kikelj D, Ma\u0161i\u010d LP et al (2019) ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents. Expert Opin Ther Pat 29(3):171\u2013180","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"11490_CR15","doi-asserted-by":"publisher","first-page":"e3003208","DOI":"10.1371\/journal.pbio.3003208","volume":"23","author":"P-Y Song","year":"2025","unstructured":"Song P-Y, Tsai C-E, Chen Y-C, Huang Y-W, Chen P-P, Wang T-H et al (2025) An interbacterial cysteine protease toxin inhibits cell growth by targeting type II DNA topoisomerases GyrB and ParE. PLoS Biol 23(5):e3003208","journal-title":"PLoS Biol"},{"key":"11490_CR16","doi-asserted-by":"crossref","unstructured":"Sofi FA, Masoodi MH, Tabassum N (2025) Recent advancements in the development of next-generation dual-targeting antibacterial agents. RSC Med Chem","DOI":"10.1039\/D4MD00934G"},{"key":"11490_CR17","doi-asserted-by":"publisher","first-page":"1419242","DOI":"10.3389\/fchem.2024.1419242","volume":"12","author":"LH Al-Wahaibi","year":"2024","unstructured":"Al-Wahaibi LH, Mahmoud MA, Alzahrani HA, Abou-Zied HA, Gomaa HA, Youssif BG et al (2024) Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and topoisomerase IV inhibitors endowed with antibacterial properties. Front Chem 12:1419242","journal-title":"Front Chem"},{"key":"11490_CR18","doi-asserted-by":"publisher","first-page":"1493906","DOI":"10.3389\/fchem.2024.1493906","volume":"12","author":"LH Al-Wahaibi","year":"2024","unstructured":"Al-Wahaibi LH, Mahmoud MA, Alzahrani HA, Abou-Zied HA, Abdelmoez A, Youssif BG et al (2024) Synthesis, enzyme inhibition, and docking studies of new schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents. Front Chem 12:1493906","journal-title":"Front Chem"},{"issue":"11","key":"11490_CR19","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.3390\/pharmaceutics15112554","volume":"15","author":"A Rusu","year":"2023","unstructured":"Rusu A, Moga I-M, Uncu L, Hancu G (2023) The role of five-membered heterocycles in the molecular structure of antibacterial drugs used in therapy. Pharmaceutics 15(11):2554","journal-title":"Pharmaceutics"},{"issue":"6","key":"11490_CR20","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/cbdd.14100","volume":"100","author":"D Tiwari","year":"2022","unstructured":"Tiwari D, Narang R, Sudhakar K, Singh V, Lal S, Devgun M (2022) 1, 3, 4\u2010oxadiazole derivatives as potential antimicrobial agents. Chem Biol Drug Des 100(6):1086\u20131121","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"11490_CR21","first-page":"611","volume":"14","author":"PB Parekar","year":"2023","unstructured":"Parekar PB, Sonwane SD, Dhakane VN, Tilekar RN, Bhagdewani NS, Jadhav SM et al (2023) Synthesis and biological evaluationof novel 1, 3, 4-oxadiazole derivatives as antimicrobial agents. J Cardiovascu Dis Res 14(8):611\u2013624","journal-title":"J Cardiovascu Dis Res"},{"key":"11490_CR22","doi-asserted-by":"publisher","first-page":"135775","DOI":"10.1016\/j.molstruc.2023.135775","volume":"1289","author":"AA AL-Sharabi","year":"2023","unstructured":"AL-Sharabi AA, Saffour S, Evren AE, Bayaz\u0131t G, \u00c7ongur G, G\u00fcl \u00dcD et al (2023) Synthesis, antimicrobial activity, electrochemical studies and molecular modeling studies of novel 1, 3, 4-oxadiazole derivatives. J Mol Struct 1289:135775","journal-title":"J Mol Struct"},{"issue":"3","key":"11490_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s11030-021-10287-3","volume":"26","author":"TR Allaka","year":"2022","unstructured":"Allaka TR, Kummari B, Polkam N, Kuntala N, Chepuri K, Anireddy JS (2022) Novel heterocyclic 1, 3, 4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: synthesis and computational molecular modeling. Mol Divers 26(3):1581\u20131596","journal-title":"Mol Divers"},{"key":"11490_CR24","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.bioorg.2021.104920","volume":"112","author":"HA Hofny","year":"2021","unstructured":"Hofny HA, Mohamed MF, Gomaa HA, Abdel-Aziz SA, Youssif BG, El-Koussi NA et al (2021) Design, synthesis, and antibacterial evaluation of new quinoline-1, 3, 4-oxadiazole and quinoline-1, 2, 4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Bioorg Chem 112:104920","journal-title":"Bioorg Chem"},{"issue":"5","key":"11490_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph14050399","volume":"14","author":"LH Al-Wahaibi","year":"2021","unstructured":"Al-Wahaibi LH, Amer AA, Marzouk AA, Gomaa HA, Youssif BG, Abdelhamid AA (2021) Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors. Pharmaceuticals 14(5):399","journal-title":"Pharmaceuticals"},{"issue":"11","key":"11490_CR26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.4314\/tjpr.v17i11.18","volume":"17","author":"AA Alkhaldi","year":"2018","unstructured":"Alkhaldi AA, Abdelgawad MA, Youssif BG (2018) Synthesis, antimicrobial evaluation and docking studies of new pyrazolone derivatives. Trop J Pharm Res 17(11):2235\u20132241","journal-title":"Trop J Pharm Res"},{"issue":"5","key":"11490_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4314\/tjpr.v18i5.27","volume":"18","author":"AA Alkhaldi","year":"2019","unstructured":"Alkhaldi AA, Abdelgawad MA, Youssif BG, El-Gendy AO, De Koning HP (2019) Synthesis, antimicrobial activities and GAPDH docking of novel 1, 2, 3-triazole derivatives. Trop J Pharm Res 18(5):1101\u20131108","journal-title":"Trop J Pharm Res"},{"key":"11490_CR28","doi-asserted-by":"publisher","first-page":"105363","DOI":"10.1016\/j.bioorg.2021.105363","volume":"116","author":"LH Al-Wahaibi","year":"2021","unstructured":"Al-Wahaibi LH, Mostafa A, Mostafa YA, Abou-Ghadir OF, Abdelazeem AH, Gouda AM et al (2021) Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease. Bioorg Chem 116:105363","journal-title":"Bioorg Chem"},{"issue":"47","key":"11490_CR29","doi-asserted-by":"publisher","first-page":"47261","DOI":"10.1021\/acsomega.4c08365","volume":"9","author":"LH Al-Wahaibi","year":"2024","unstructured":"Al-Wahaibi LH, Rabea SM, Mahmoud MA, Youssif BG, Br\u00e4se S, Abdel-Aziz SA (2024) Synthesis and antimicrobial evaluation of new 1, 2, 4-triazolo [1, 5-a] pyrimidine-based derivatives as dual inhibitors of bacterial DNA gyrase and DHFR. ACS Omega 9(47):47261\u201347273","journal-title":"ACS Omega"},{"key":"11490_CR30","doi-asserted-by":"publisher","first-page":"134902","DOI":"10.1016\/j.molstruc.2023.134902","volume":"1278","author":"MA Elbastawesy","year":"2023","unstructured":"Elbastawesy MA, Mohamed FA, Zaki I, Alahmdi MI, Alzahrani SS, Alzahrani HA et al (2023) Design, synthesis and antimicrobial activity of novel quinoline-2-one hybrids as promising DNA gyrase and topoisomerase IV inhibitors. J Mol Struct 1278:134902","journal-title":"J Mol Struct"},{"issue":"7","key":"11490_CR31","doi-asserted-by":"publisher","first-page":"2100516","DOI":"10.1002\/ardp.202100516","volume":"355","author":"FO Frejat","year":"2022","unstructured":"Frejat FO, Cao Y, Wang L, Zhai H, Abdelazeem AH, Gomaa HA et al (2022) New 1, 2, 4\u2010oxadiazole\/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity. Arch Pharm (Weinheim) 355(7):2100516","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"11490_CR32","doi-asserted-by":"publisher","first-page":"103538","DOI":"10.1016\/j.arabjc.2021.103538","volume":"15","author":"FOA Frejat","year":"2022","unstructured":"Frejat FOA, Cao Y, Zhai H, Abdel-Aziz SA, Gomaa HA, Youssif BG et al (2022) Novel 1, 2, 4-oxadiazole\/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity. Arab J Chem 15(1):103538","journal-title":"Arab J Chem"},{"key":"11490_CR33","doi-asserted-by":"publisher","first-page":"103782","DOI":"10.1016\/j.bioorg.2020.103782","volume":"99","author":"TS Ibrahim","year":"2020","unstructured":"Ibrahim TS, Bokhtia RM, Al-Mahmoudy AM, Taher ES, AlAwadh MA, Elagawany M et al (2020) Design, synthesis and biological evaluation of novel 5-((substituted quinolin-3-yl\/1-naphthyl) methylene)-3-substituted imidazolidin-2, 4-dione as HIV-1 fusion inhibitors. Bioorg Chem 99:103782","journal-title":"Bioorg Chem"},{"key":"11490_CR34","doi-asserted-by":"publisher","first-page":"116704","DOI":"10.1016\/j.ejmech.2024.116704","volume":"277","author":"AM Shawky","year":"2024","unstructured":"Shawky AM, Almalki FA, Alzahrani HA, Abdalla AN, Youssif BG, Ibrahim NA et al (2024) Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: insights into their design, classification, biological activity, and binding interactions. Eur J Med Chem 277:116704","journal-title":"Eur J Med Chem"},{"key":"11490_CR35","doi-asserted-by":"publisher","first-page":"103933","DOI":"10.1016\/j.bioorg.2020.103933","volume":"100","author":"MS Shaykoon","year":"2020","unstructured":"Shaykoon MS, Marzouk AA, Soltan OM, Wanas AS, Radwan MM, Gouda AM et al (2020) Design, synthesis and antitrypanosomal activity of heteroaryl-based 1, 2, 4-triazole and 1, 3, 4-oxadiazole derivatives. Bioorg Chem 100:103933","journal-title":"Bioorg Chem"},{"issue":"2","key":"11490_CR36","first-page":"54","volume":"4","author":"BG Youssif","year":"2014","unstructured":"Youssif BG, Abdel-Moty SG, Sayed IM (2014) Synthesis and biological evaluation of some novel 1, 2, 3-triazol-N-arylidene acetohydrazide incorporating benzimidazole ring moiety as potential antimicrobial agents. J Curr Chem Pharm Sci 4(2):54\u201364","journal-title":"J Curr Chem Pharm Sci"},{"key":"11490_CR37","first-page":"39","volume-title":"DNA Supercoiling catalyzed by bacterial gyrase. Topoisomerases: methods and protocols","author":"S Joshi","year":"2025","unstructured":"Joshi S, Osheroff N (2025) DNA Supercoiling catalyzed by bacterial gyrase. Topoisomerases: methods and protocols. Springer, Berlin, pp 39\u201350"},{"issue":"2","key":"11490_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3(2):163\u2013175","journal-title":"Nat Protoc"},{"issue":"2","key":"11490_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/antibiotics14020156","volume":"14","author":"EA Portal","year":"2025","unstructured":"Portal EA, Farley C, Iannetelli T, Coelho J, Efstratiou A, Bentley SD et al (2025) Agar-dilution is comparable to broth dilution for MIC determination in Streptococcus agalactiae. Antibiotics (Basel) 14(2):156","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"11490_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/14756366.2022.2151593","volume":"38","author":"LH Al-Wahaibi","year":"2023","unstructured":"Al-Wahaibi LH, Mahmoud MA, Mostafa YA, Raslan AE, Youssif BG (2023) Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway. J Enzyme Inhib Med Chem 38(1):376\u2013386","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11490_CR41","doi-asserted-by":"publisher","first-page":"135165","DOI":"10.1016\/j.molstruc.2023.135165","volume":"1282","author":"MA Mahmoud","year":"2023","unstructured":"Mahmoud MA, Mohammed AF, Salem OI, Rabea SM, Youssif BG (2023) Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR\/VEGFR-2 inhibitors. J Mol Struct 1282:135165","journal-title":"J Mol Struct"},{"key":"11490_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-031-91863-6_1","volume-title":"Introduction to microbial biofilms. Omics approaches in biofilm research: perspectives and applications","author":"ZT Ahmed","year":"2025","unstructured":"Ahmed ZT, Singh P, Saraswathi A, Deekshitha S, Kumar RR, Thacharodi A et al (2025) Introduction to microbial biofilms. Omics approaches in biofilm research: perspectives and applications. Springer, Berlin, pp 3\u201343"},{"key":"11490_CR43","doi-asserted-by":"publisher","first-page":"1670237","DOI":"10.3389\/fcimb.2025.1670237","volume":"15","author":"H Ben","year":"2025","unstructured":"Ben H, Agarwal H, Gurnani B, Pradhan AA, Khan AA, Jain N (2025) Breaking the barrier: disruption of bacterial biofilms using microwave radiation. Front Cell Infect Microbiol 15:1670237","journal-title":"Front Cell Infect Microbiol"},{"key":"11490_CR44","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhong Y, Wang Y, Wang H, Hong S, Zhang Y, et al. (2026) A self-assembled nanophotosensitizer effectively inactivates biofilm-related infections. ACS Mater Lett","DOI":"10.1021\/acsmaterialslett.5c01432"},{"key":"11490_CR45","first-page":"445","volume":"57","author":"P Wan","year":"2026","unstructured":"Wan P, Hua T, Zhao X, Deng M, Chen L, Xiao C et al (2026) Tertiary alkylamine-functionalized polyaspartamides with potent antibacterial activity. Bioact Mater 57:445\u2013456","journal-title":"Bioact Mater"},{"key":"11490_CR46","doi-asserted-by":"crossref","unstructured":"Khan MSA, Altaf MM, Ahmad I (2017) Chemical nature of biofilm matrix and its significance. Biofilms Plant Soil Health 151\u201377","DOI":"10.1002\/9781119246329.ch9"},{"key":"11490_CR47","doi-asserted-by":"crossref","unstructured":"Hu Y-Y, Finkel ZV (2025) Lipids in microalgae: Quantitation by acid-dichromate method in microtiter plate","DOI":"10.17504\/protocols.io.e6nvw9dpzgmk\/v3"},{"key":"11490_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143066","author":"AR Rabee","year":"2025","unstructured":"Rabee AR, Hagar M, Soliman SM, Abdel-Hamid H, Jaremko M, Emwas A-H et al (2025) Design and synthesis of new 1, 2, 3-triazole\/benzimidazole hybrids using Click reaction: antibacterial evaluation, molecular docking, and DFT analysis. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143066","journal-title":"J Mol Struct"},{"issue":"1","key":"11490_CR49","first-page":"5084553","volume":"2024","author":"IH Eissa","year":"2024","unstructured":"Eissa IH, Saleh AM, Al-Rashood ST, El-Attar A-AM, Metwaly AM (2024) Multistaged in silico discovery of the best SARS\u2010CoV\u20102 main protease inhibitors amongst 3009 clinical and FDA\u2010approved compounds. J Chem 2024(1):5084553","journal-title":"J Chem"},{"issue":"1","key":"11490_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.37033\/fjc.v10i1.713","volume":"10","author":"VI Paat","year":"2025","unstructured":"Paat VI, Aloanis AA, Najoan JMJ (2025) Molecular docking of Cyclosenegalin A as anticancer. Fullerene J Chem 10(1):26\u201333","journal-title":"Fullerene J Chem"},{"issue":"6","key":"11490_CR51","doi-asserted-by":"publisher","first-page":"e70110","DOI":"10.1002\/bmc.70110","volume":"39","author":"A Seghir","year":"2025","unstructured":"Seghir A, Mokhtar M, Azzam KMA, Nadia B, Aytar EC, Saad A et al (2025) Comprehensive chemical profiling of Moringa oleifera leaves extracts by LC\u2013MS\/MS followed by in silico ADMET prediction using SwissADME. Biomed Chromatogr 39(6):e70110","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"11490_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.47852\/bonviewMEDIN42023842","volume":"2","author":"FB Tessema","year":"2025","unstructured":"Tessema FB, Asfaw TB, Tadesse MG, Gonfa YH, Bachheti RK (2025) In silico studies as support for natural products research. Medinformatics 2(1):11\u201321","journal-title":"Medinformatics"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11490-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:02:01Z","timestamp":1783162921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11490-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11490"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11490-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}]}}